Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 13.46% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Industrials | 10.52% |
| 5 | Consumer Staples | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CEL
251
DELISTED
Cellcom Israel, Ltd.
CEL
| $38M | 0.09% |
3,145,499
+49,083
| +2% | +$643K |
|
252
Charter Communications
CHTR
$18.8B
| $37.9M | 0.09% |
239,600
+213,624
| +822% | +$29.5M |
|
|
DNKN
253
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $37.9M | 0.09% |
827,400
+268,100
| +48% | +$12.3M |
|
254
Monster Beverage
MNST
$89.2B
| $37.8M | 0.09% |
6,387,600
+5,607,168
| +718% | +$32M |
|
255
Ziff Davis
ZD
$1.83B
| $37.8M | 0.09% |
854,335
-148,350
| -15% | -$6.19M |
|
|
CPN
256
DELISTED
Calpine Corporation
CPN
| $37.7M | 0.09% |
1,584,800
-1,077,449
| -40% | -$24.4M |
|
257
Plains All American Pipeline
PAA
$16.3B
| $37.1M | 0.09% |
618,314
-475,866
| -43% | -$27.1M |
|
258
Hormel Foods
HRL
$13.4B
| $37M | 0.09% |
1,500,400
+303,800
| +25% | +$7.34M |
|
|
TLM
259
DELISTED
TALISMAN ENERGY INC
TLM
| $36.8M | 0.09% |
3,475,700
-888,888
| -20% | -$9.28M |
|
260
Amgen
AMGN
$224B
| $36.8M | 0.09% |
310,645
-22,704
| -7% | -$2.63M |
|
261
Carnival Corporation Ltd
CCL
$38B
| $36.7M | 0.09% |
974,100
-141,900
| -13% | -$5.5M |
|
|
DCM
262
DELISTED
NTT DOCOMO, Inc.
DCM
| $36.6M | 0.09% |
2,141,900
+38,100
| +2% | +$620K |
|
263
HSBC
HSBC
$355B
| $36.5M | 0.09% |
834,531
+324,494
| +64% | +$14.5M |
|
264
Altria Group
MO
$109B
| $36.4M | 0.08% |
868,100
+853,400
| +5,805% | +$34.3M |
|
265
Edison International
EIX
$26.9B
| $36.3M | 0.08% |
+624,900
| New | +$35M |
|
266
Rockwell Automation
ROK
$49.6B
| $36.1M | 0.08% |
288,100
-144,600
| -33% | -$17.8M |
|
267
NVIDIA
NVDA
$5.27T
| $36M | 0.08% |
77,763,080
-125,992,600
| -62% | -$58.9M |
|
268
Enbridge
ENB
$113B
| $36M | 0.08% |
758,769
+689,600
| +997% | +$32.7M |
|
|
STJ
269
DELISTED
St Jude Medical
STJ
| $35.7M | 0.08% |
+516,013
| New | +$33.5M |
|
270
Ryman Hospitality Properties
RHP
$7.7B
| $35.3M | 0.08% |
733,441
+110,584
| +18% | +$5.08M |
|
271
JetBlue
JBLU
$2.19B
| $35M | 0.08% |
3,224,400
+1,032,297
| +47% | +$9.54M |
|
272
FedEx
FDX
$76.3B
| $34.8M | 0.08% |
+229,800
| New | +$32.1M |
|
273
UGI
UGI
$7.54B
| $34.6M | 0.08% |
1,027,050
+380,850
| +59% | +$12M |
|
|
STI
274
DELISTED
SunTrust Banks, Inc.
STI
| $34.6M | 0.08% |
863,017
+508,200
| +143% | +$19.8M |
|
275
Deutsche Bank
DB
$71.8B
| $34.5M | 0.08% |
+1,098,951
| New | +$39.2M |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.